Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760799 · ClinicalTrials.gov registry record · Phase 4
Randomized Study of Anular Repair With the Xclose Tissue Repair System
A Phase 4 study of Diskectomy, sponsored by Anulex Technologies.
- Completed
- Registry status
- Phase 4
- Development phase
- 750
- Enrollment target
- 20
- Study locations
NCT00760799: Completed Phase 4 study of Diskectomy, sponsored by Anulex Technologies.
NCT00760799 is a Phase 4 study of Diskectomy that has completed, run by Anulex Technologies. The registered enrollment target is 750 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00760799, a Phase 4 study of Diskectomy, has completed, sponsored by Anulex Technologies.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 750 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the benefits of anulus fibrosus repair utilizing Xclose™ compared to a discectomy without anulus fibrosus repair.
Conditions Studied
Interventions
- PROCEDURE Discectomy with anular repair
Study Locations (20)
Florida
- North Florida Regional Hospital - Gainesville
- Lyerly Neurosurgical (Baptist Health) - Jacksonville
- Mayo Clinic - Jacksonville
- Lyerly Neurosurgical (Centerone) - Jacksonville
Illinois
- Midwest Orthopaedics at Rush - Chicago
- Chicago Institute of Neurosurgery and Neuroresearch - Chicago
- Palos Community Hospital - Palos Heights
Arizona
- Texas Back Institute - Phoenix
- Desert Institute for Spine Care - Phoenix
Colorado
- Denver Spine (Porter Hospital) - Greenwood Village
- Denver Spine (Presbyterian/St. Luke's Hospital) - Greenwood Village
Michigan
- Oakwood Hospital - Dearborn
- Henry Ford - Detroit
Alabama
- North Alabama Neurological, P.A. - Huntsville
California
- University of California San Diego - San Diego
Indiana
- Indiana Spine Group - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-01 |
| Phase | Phase 4 |
What the finished NCT00760799 record still lists
NCT00760799 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% higher).
The record links to 1 condition, with Diskectomy appearing as the primary indexed condition, and to 1 intervention - of which Discectomy with anular repair is the first listed.
NCT00760799 names 20 study sites across 12 states, led by Florida, Illinois, Arizona.
Frequently Asked Questions
What is clinical trial NCT00760799 about?
NCT00760799 is a clinical study titled "Randomized Study of Anular Repair With the Xclose Tissue Repair System". The purpose of this study is to evaluate the benefits of anulus fibrosus repair utilizing Xclose™ compared to a discectomy without anulus fibrosus repair.
What is the current status of trial NCT00760799?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 750 participants. The study started on 2007-03. Estimated completion is 2012-01.
What conditions does trial NCT00760799 study?
This clinical trial studies the following conditions: Diskectomy.
What interventions are being tested in trial NCT00760799?
The interventions under investigation include: Discectomy with anular repair (PROCEDURE).
Who is sponsoring clinical trial NCT00760799?
This trial is sponsored by Anulex Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00760799 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diskectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00760799's enrollment target sits among peer trials
750 108th of 2000 higher than 1,891 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia